25,214 Shares in GRAIL, Inc. $GRAL Purchased by Scientech Research LLC

Key Points

• Scientech Research LLC acquired 25,214 shares of GRAIL, Inc., valued at approximately $644,000, representing about 0.07% ownership of the company as of the latest SEC filing.
• GRAIL reported a loss of ($3.18) earnings per share for the most recent quarter, which was below analysts' expectations, along with a revenue of $35.54 million.
• Canaccord Genuity Group upgraded GRAIL's target price from $32.00 to $43.00, maintaining a "buy" rating, while the consensus rating remains "Hold" with a price target of $31.50.

Scientech Research LLC bought a new position in GRAIL, Inc. (NASDAQ:GRAL - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 25,214 shares of the company's stock, valued at approximately $644,000. Scientech Research LLC owned 0.07% of GRAIL at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the company. NewEdge Advisors LLC raised its position in shares of GRAIL by 390.3% in the 1st quarter. NewEdge Advisors LLC now owns 1,760 shares of the company's stock worth $45,000 after buying an additional 1,401 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in GRAIL by 28.2% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,835 shares of the company's stock valued at $76,000 after purchasing an additional 623 shares during the period. AQR Capital Management LLC raised its position in GRAIL by 61.0% in the first quarter. AQR Capital Management LLC now owns 1,337,163 shares of the company's stock valued at $33,991,000 after purchasing an additional 506,440 shares during the period. Royal Bank of Canada raised its position in GRAIL by 17.7% in the first quarter. Royal Bank of Canada now owns 88,082 shares of the company's stock valued at $2,250,000 after purchasing an additional 13,264 shares during the period. Finally, Quarry LP raised its position in GRAIL by 1,965.4% in the first quarter. Quarry LP now owns 2,148 shares of the company's stock valued at $55,000 after purchasing an additional 2,044 shares during the period.

GRAIL Trading Down 1.6%

NASDAQ:GRAL traded down $0.61 during mid-day trading on Friday, hitting $38.04. The company had a trading volume of 519,444 shares, compared to its average volume of 678,706. The business has a fifty day simple moving average of $35.66 and a 200-day simple moving average of $35.52. GRAIL, Inc. has a 1 year low of $12.33 and a 1 year high of $63.99. The firm has a market capitalization of $1.37 billion, a price-to-earnings ratio of -2.90 and a beta of 3.18.

GRAIL (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. The company reported ($3.18) EPS for the quarter, missing the consensus estimate of ($3.14) by ($0.04). GRAIL had a negative net margin of 329.86% and a negative return on equity of 16.64%. The company had revenue of $35.54 million during the quarter, compared to analysts' expectations of $37.57 million. As a group, research analysts anticipate that GRAIL, Inc. will post -15.15 earnings per share for the current year.

Insider Buying and Selling at GRAIL

In other news, President Joshua J. Ofman sold 9,692 shares of the firm's stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $52.00, for a total transaction of $503,984.00. Following the completion of the sale, the president directly owned 492,076 shares in the company, valued at $25,587,952. This trade represents a 1.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Aaron Freidin sold 8,000 shares of the firm's stock in a transaction dated Tuesday, July 15th. The shares were sold at an average price of $38.93, for a total value of $311,440.00. Following the sale, the chief financial officer owned 286,020 shares of the company's stock, valued at $11,134,758.60. This represents a 2.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 361,694 shares of company stock valued at $17,780,266 over the last three months. 1.85% of the stock is owned by company insiders.

GRAIL Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.